SCHEMBL23212819

SCHEMBL23212819

CC(c1nccnc1-c1ccc(Cl)cn1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.37
KMT2A Q03164 3/20 0.37
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
LMNA P02545 1/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ATM Q13315 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 2/20 0.33
GAA P10253 1/20 0.33
TGFBR1 P36897 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30069472 0.85 LMNA (0.35) SMN1; SMN2KMT2AFNTAFNTBLMNA
SCHEMBL24728672 0.85 LMNA (0.35) SMN1; SMN2KMT2AFNTAFNTBLMNA
SCHEMBL29775963 0.83 HPGD (0.41) SMN1; SMN2KMT2AALDH1A1NPSR1
SCHEMBL23212678 0.83 HPGD (0.41) SMN1; SMN2KMT2AALDH1A1NPSR1
SCHEMBL23212709 0.83 LMNA (0.42) KMT2ALMNAALDH1A1MEN1CYP1A2
SCHEMBL30010484 0.82 TRPV1 (0.35) LMNAALDH1A1ALOX15
SCHEMBL23212691 0.82 LMNA (0.44) SMN1; SMN2KMT2ALMNAALOX15TGFBR1
SCHEMBL23213969 0.82 TRPV1 (0.35) LMNAALDH1A1ALOX15
SCHEMBL24728835 0.81 ALOX15 (0.41) SMN1; SMN2LMNAALDH1A1ALOX15TSHR
SCHEMBL24729152 0.81 ALOX15 (0.41) SMN1; SMN2LMNAALDH1A1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583851-B2 Heteroaryl-substituted pyrazine derivatives as pesticides ELANCO ANIMAL HEALTH GMBH (DE) 2026-03-24 US disclosed
US-20230023326-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-01-26 US disclosed
US-20230023326-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-01-26 US disclosed
EP-4041720-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES Bayer Animal Health GmbH (DE) 2022-08-17 EP disclosed
WO-2021069575-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES BAYER ANIMAL HEALTH GMBH (DE) 2021-04-15 WO disclosed
WO-2021069575-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES BAYER ANIMAL HEALTH GMBH (DE) 2021-04-15 WO disclosed
US-20160361448-A1 CONTRAST AGENTS FOR APPLICATIONS INCLUDING PERFUSION IMAGING LANTHEUS MEDICAL IMAGING, INC. (US) 2016-12-15 US disclosed
US-20160362375-A1 Iodine(III)-Mediated Radiofluorination THE GENERAL HOSPITAL CORPORATION 2016-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583851-B2 Heteroaryl-substituted pyrazine derivatives as pesticides CBR3, CYCS, CWC15 SMN1; SMN2 2723/4885KMT2A 3192/4885FNTA 2573/4885
US-20230023326-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES DDT, PRXL2A, CAT SMN1; SMN2 4441/4885KMT2A 2752/4885FNTA 2181/4885
US-20160361448-A1 CONTRAST AGENTS FOR APPLICATIONS INCLUDING PERFUSION IMAGING MCOLN1, CNR1, SLC5A7 SMN1; SMN2 774/4885KMT2A 3906/4885FNTA 3617/4885
US-20160362375-A1 Iodine(III)-Mediated Radiofluorination TPO, FLI1, SSTR3 SMN1; SMN2 4649/4885KMT2A 1626/4885FNTA 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.